** ASX-listed shares of Revasum Inc RVS.AX rise as much as
12% to A$0.655, marking biggest intraday pct gain since Dec 8
** U.S.-based semiconductor maker sees FY22 revenue between
$25 mln and $35 mln vs FY21 forecast of $13.3 mln to $15.6 mln
urn:newsml:reuters.com:*:nASXRhsNC
** RVS also expects to be free cash flow positive in FY22
** Says it now has purchase orders confirmed for seven
pieces of equipment and a $8.2 mln backlog as at Dec 21
** Stock's volumes are 3.7 times the 30-day average of
172,374 shares
** As of last close, stock up 79.7% this year
(Reporting by Himanshi Akhand in Bengaluru)
((Himanshi.Akhand@thomsonreuters.com;))